ישראל -
עברית -
Ministry of Health
אימנד 80 מג קפסולות
merck sharp & dohme israel ltd - aprepitant - קפסולות - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
ישראל -
עברית -
Ministry of Health
אימנד 80 מג קפסולות
merck sharp & dohme israel ltd - aprepitant - קפסולות - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
ישראל -
עברית -
Ministry of Health
אימנד 80 מג קפסולות
merck sharp & dohme (israel - 1996) company ltd, israel - aprepitant - קפסולות - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
ישראל -
עברית -
Ministry of Health
אימנד 125 מג קפסולות
merck sharp & dohme israel ltd - aprepitant - קפסולות - aprepitant 125 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
ישראל -
עברית -
Ministry of Health
אימנד 125 מג קפסולות
merck sharp & dohme (israel - 1996) company ltd, israel - aprepitant - קפסולות - aprepitant 125 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
ישראל -
עברית -
Ministry of Health
אימנד 125 מג קפסולות
merck sharp & dohme israel ltd - aprepitant - קפסולות - aprepitant 125 mg - aprepitant
ישראל -
עברית -
Ministry of Health
אוטזלה 10 מג
amgen europe b.v. - apremilast - טבליות מצופות פילם - apremilast 10 mg - apremilast
ישראל -
עברית -
Ministry of Health
אוטזלה 10 מג
amgen europe b.v. - apremilast - טבליות מצופות פילם - apremilast 10 mg - apremilast
ישראל -
עברית -
Ministry of Health
אוטזלה 10 מג
amgen europe b.v. - apremilast - טבליות מצופות פילם - apremilast 10 mg - apremilast
ישראל -
עברית -
Ministry of Health
אוטזלה 10 מג
amgen europe b.v. - apremilast - טבליות מצופות פילם - apremilast 10 mg - apremilast